Trials / Completed
CompletedNCT01840540
MSC for Occlusive Disease of the Kidney
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety and toxicity of intra-arterial infused autologous adipose derived mesenchymal stromal (stem) cells in patients with vascular occlusive disease of the kidney.
Detailed description
Individuals with unilateral arterial occlusive disease will be treated to injured kidney with autologous cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Arterial infusion of autologous mesenchymal stem cells |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-03-01
- Completion
- 2017-04-01
- First posted
- 2013-04-25
- Last updated
- 2017-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01840540. Inclusion in this directory is not an endorsement.